These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 39213146

  • 1. Real-world treatment patterns, health care resource utilization, and costs in a US Medicare population with bronchiectasis.
    Tkacz J, Lewing B, Feliciano J, Mohanty M, Lauterio M, Fucile S, Barker A.
    J Manag Care Spec Pharm; 2024 Sep; 30(9):967-977. PubMed ID: 39213146
    [Abstract] [Full Text] [Related]

  • 2. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
    Jain R, Fu AC, Lim J, Wang C, Elder J, Sander SD, Tan H.
    J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
    [Abstract] [Full Text] [Related]

  • 3. Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States.
    Varnado OJ, Vu M, Buysman E, Kim G, Allenback G, Hoyt M, Trenz H, Cao F, Viktrup L.
    J Manag Care Spec Pharm; 2024 Aug; 30(8):792-804. PubMed ID: 39088336
    [Abstract] [Full Text] [Related]

  • 4. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ, Pal SK, Ghate SR, Li N, Swallow E, Peeples M, Zichlin ML, Meiselbach MK, Perez JR, Agarwal N.
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [Abstract] [Full Text] [Related]

  • 5. The economic burden of bronchiectasis - known and unknown: a systematic review.
    Goeminne PC, Hernandez F, Diel R, Filonenko A, Hughes R, Juelich F, Solomon GM, Upton A, Wichmann K, Xu W, Chalmers JD.
    BMC Pulm Med; 2019 Feb 28; 19(1):54. PubMed ID: 30819166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
    To TM, Exuzides A, Abbass IM, Patel AM, Ta JT, Surinach A, Fuller RLM, Luo J.
    J Manag Care Spec Pharm; 2022 Nov 28; 28(11):1228-1239. PubMed ID: 36282937
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
    Heresi G, Dean B, Wu B, Lee H, Sketch MR, Stafkey-Mailey D, Morland K, Classi P, Spikes L.
    BMC Pulm Med; 2024 Jul 11; 24(1):335. PubMed ID: 38992626
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Economic Burden of Treatment-Resistant Depression on the U.S. Health Care System.
    Sussman M, O'sullivan AK, Shah A, Olfson M, Menzin J.
    J Manag Care Spec Pharm; 2019 Jul 11; 25(7):823-835. PubMed ID: 31232205
    [Abstract] [Full Text] [Related]

  • 15. Healthcare resource utilization and costs associated with hepatitis A in the United States: a retrospective database analysis.
    Samant S, Chen E, Carias C, Kujawski SA.
    J Med Econ; 2024 Jul 11; 27(1):1046-1052. PubMed ID: 39092467
    [Abstract] [Full Text] [Related]

  • 16. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
    Toro W, Yang M, Georgieva M, Song W, Patel A, Jiang AX, Zhao A, LaMarca N, Dabbous O.
    Adv Ther; 2023 Oct 11; 40(10):4589-4605. PubMed ID: 37587305
    [Abstract] [Full Text] [Related]

  • 17. Health care resource utilization and burden of disease in a U.S. Medicare population with a principal diagnosis of osteoarthritis of the knee.
    Chen F, Su W, Bedenbaugh AV, Oruc A.
    J Med Econ; 2020 Oct 11; 23(10):1151-1158. PubMed ID: 32715848
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag.
    Cai B, Said Q, Li X, Li FY, Arcona S.
    J Med Econ; 2020 Mar 11; 23(3):243-251. PubMed ID: 31686551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.